Beech Tree Labs is developing innovative therapies to address critical patient conditions. The Company’s lead product is TML that adresses serious viral infections. Preliminary efforts are also being directed towards developing products for the treatment of muscular dystrophy and Parkinson’s disease.
Status of the products: